The detection of such common variants provides an alternative to sequencing of the tumor tissue in contexts in which the prevalence of these variants is frequent, such as the detection of KRAS mutations in colorectal cancers [11] and Epidermal Growth Factor Receptor (EGFR)mutations in lung cancer [12]. The gene discussed is EGFR; the disease is neoplasm.